Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Public Health and Preventive Medicine
  4. Vol 2, Issue 3, 2022

Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy

Download as PDF

DOI: 10.23977/phpm.2022.020311 | Downloads: 10 | Views: 629

Author(s)

Honggao Duan 1

Affiliation(s)

1 School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Benxi, Liaoning Province, 117004, China

Corresponding Author

Honggao Duan

ABSTRACT

Diabetic peripheral neuropathy has a serious impact on the health and quality of life of patients. At present, the disease is mainly treated by aldose reductase inhibitors and other drugs. These drugs can effectively relieve the clinical symptoms of patients, and have good improvement effect on their neurological function, which can delay the development of the disease to a large extent. In clinical treatment, for the treatment of the disease, mainly in the premise of stable control of blood sugar, give patients the corresponding drug adjuvant treatment. In this paper, on the basis of consulting the relevant literature, we analyzed the progress of drug treatment of patients.

KEYWORDS

Drug therapy, Metabolic disorder, Microcirculation, Nerve repair

CITE THIS PAPER

Honggao Duan, Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy. MEDS Public Health and Preventive Medicine (2022) Vol. 2: 66-70. DOI: http://dx.doi.org/10.23977/phpm.2022.020311.

REFERENCES

[1] Zhang Meiqin, Yan Jimin. Clinical study of lipoic acid combined with Mecobalamin in the treatment of type 2 diabetic peripheral neuropathy [J]. Modern medicine and clinic, 2021,36 (02): 321-325.
[2] Miao Kexin. Effect of α-lipoic acid combined with Mecobalamin in the treatment of diabetic peripheral neuropathy [J]. Shanxi Medical Journal, 2021,50 (03): 393-395.
[3] Wang Ying, Zhang Liping, Sun Hongfeng. Clinical observation on Tongluo Xiaobi Decoction foot bath combined with Acupoint Application in the treatment of diabetic peripheral neuropathy of cold coagulation and blood stasis type [J] Medical review, 2021,27 (07): 1422-1427.
[4] Zhong Dayuan, Li Lan, Jiang Chengting. [J]. Molecular mechanism of Salvia miltiorrhiza in treating diabetic neuropathyActa Sinica Sinica, 2021, 36 (03): 608-613.
[5] Deng Huihui, Ning Xiaoming, Chen Ruijin. Effect of epalrestat on the efficacy and serum inflammatory factor levels in the treatment of diabetic peripheral neuropathy [J]. Jilin Medical Science, 2021,42 (05): 1134-1136.
[6] Han Yunpeng, Fu Xiaoxu, Leng Yulin. Discussion on the characteristics of blood stasis pathogenesis and treatment strategies of diabetic peripheral neuropathy [J]. Sichuan Traditional Chinese medicine, 2021,39 (04): 31-35.
[7] Liu Xiaoxia, Liu Tian, he Dongying. Clinical study of Tangmaikang Granules Combined with cilostazol in the treatment of diabetic peripheral neuropathy [J]. Chinese hospital drug evaluation and analysis, 2021,21 (05): 560-562+ 566.
[8] Xu Yanrong, Shang Hongbo, Qin Xiaoli. Clinical observation of prostaglandin E1 combined with Anisodamine hydrobromide in the treatment of ischemic diabetes feet [J]. Clinical misdiagnosis and mistreatment, 2021,34 (08): 32-37.
[9] Zhang Jiajia, Zhu Xiaodong, Chen Hongxia. Toronto score and electrophysiological analysis of patients with peripheral neuropathy treated with Jiang's Xuantong Decoction [J]. Chinese Journal of experimental prescriptions, 2021,27 (22): 125-130.
[10] Chen Ruihua. Clinical effect of lipoic acid combined with Mecobalamin in the treatment of diabetic peripheral neuropathy [J]. Journal of clinical rational drug use, 2021,14 (32): 102-103.
[11] Fu Shaojian, Yao Qiankun, Zhuo Dongbing. Clinical study of duloxetine enteric coated capsules combined with escitalopram tablets in the treatment of senile somatoform disorders [J]. Chinese Journal of clinical pharmacology, 2019,35 (22): 2840-2843.
[12] Huang Huirong, Yu Zhenling, Xue Jialu. Observation on therapeutic effect of moxibustion combined with infrared radiation on type 2 diabetic peripheral neuropathy [J]. Fujian traditional Chinese medicine, 2021,52 (07): 15-17.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 1792
Visits: 83672

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.